Warner Pharmaceuticals (688799.SH): Ferrous succinate tablets, etc. to be selected for centralized procurement of drugs from all over the country

Zhitong Finance App News, Warner Pharmaceuticals (688799.SH) announced that on July 31, 2026, the company participated in the bidding process for the 12th batch of centralized national drug procurement organized by the State Drug Joint Procurement Office. The company plans to select ferrous succinate tablets and diclofenac sustained-release tablets for this centralized procurement.

This centralized procurement is the 12th batch of centralized procurement of national drugs organized by the Joint Procurement Office. During the procurement cycle, medical institutions will prioritize the use of selected drugs and ensure that the agreed procurement volume is completed. The price of the company's proposed selection for the above products has dropped to a certain extent compared to the original sales price. If the company subsequently signs a procurement contract and executes it, it will help the above products expand cooperation channels, promote the development of the domestic market, and enhance the company's brand influence.